Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy.
Department of Hepatology and Gastroenterology, ASST GOM Niguarda Hospital, Milan, Italy.
Am J Transplant. 2022 Apr;22(4):1191-1200. doi: 10.1111/ajt.16936. Epub 2022 Jan 8.
There is increasing evidence that early liver transplantation (eLT), performed within standardized protocols can improve survival in severe alcoholic hepatitis (sAH). The aim of the study was to assess outcomes after eLT for sAH in four Italian LT centers and to compare them with non-responders to medical therapy excluded from eLT. Patients admitted for sAH (2013-2019), according to NIAAA criteria, were included. Patients not responding to medical therapy were placed on the waiting list for eLT after a strict selection. Histological features of explanted livers were evaluated. Posttransplant survival and alcohol relapse were evaluated. Ninety-three patients with severe AH were evaluated (65.6% male, median [IQR] age: 47 [42-56] years). Forty-five of 93 patients received corticosteroids, 52 of 93 were non-responders and among these, 20 patients were waitlisted. Sixteen patients underwent LT. Overall, 6-, 12-, and 24-month survival rates were 100% significantly higher compared with non-responders to medical therapy who were denied LT (45%, 45%, and 36%; p < .001). 2/16 patients resumed alcohol intake, one at 164 days and one at 184 days. Early LT significantly improves survival in sAH non-responding to medical therapy, when a strict selection process is applied. Further studies are needed to properly assess alcohol relapse rates.
越来越多的证据表明,在标准化方案内进行早期肝移植(eLT)可以改善严重酒精性肝炎(sAH)患者的生存率。本研究旨在评估意大利四个 LT 中心进行 sAH 的 eLT 后的结果,并与未接受 eLT 的对药物治疗无反应的患者进行比较。纳入符合 NIAAA 标准的 sAH 入院患者。对药物治疗无反应的患者在经过严格筛选后被列入 eLT 的等待名单。评估了移植肝脏的组织学特征。评估了移植后生存和酒精复发情况。共评估了 93 例严重 AH 患者(65.6%为男性,中位[IQR]年龄:47[42-56]岁)。93 例患者中有 45 例接受了皮质类固醇治疗,52 例对皮质类固醇无反应,其中 20 例被列入等待名单。16 例患者接受了 LT。总体而言,6、12 和 24 个月的生存率为 100%,明显高于被拒绝 LT 的对药物治疗无反应的患者(45%、45%和 36%;p<0.001)。16 例患者中有 2 例恢复饮酒,1 例在 164 天,1 例在 184 天。当应用严格的选择过程时,早期 LT 可显著改善对药物治疗无反应的 sAH 患者的生存率。需要进一步的研究来正确评估酒精复发率。